| Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB‐specific quality of life instrument JW Frew, LK Martin, T Nijsten, DF Murrell British Journal of Dermatology 161 (6), 1323-1330, 2009 | 127 | 2009 |
| COVID-19 and immunomodulator/immunosuppressant use in dermatology KN Price, JW Frew, JL Hsiao, VY Shi Journal of the American academy of dermatology 82 (5), e173-e175, 2020 | 122 | 2020 |
| A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa SS Venugopal, W Yan, JW Frew, HI Cohn, LM Rhodes, K Tran, ... Journal of the American Academy of Dermatology 69 (6), 898-908. e7, 2013 | 121 | 2013 |
| What causes hidradenitis suppurativa?—15 years after CC Zouboulis, F Benhadou, AS Byrd, NS Chandran, ... Experimental dermatology 29 (12), 1154-1170, 2020 | 118 | 2020 |
| Psoriasis in those planning a family, pregnant or breast‐feeding. The Australasian Psoriasis Collaboration M Rademaker, K Agnew, M Andrews, K Armour, C Baker, P Foley, J Frew, ... Australasian Journal of Dermatology 59 (2), 86-100, 2018 | 96 | 2018 |
| The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: an open-label cohort study JW Frew, K Navrazhina, D Grand, M Sullivan-Whalen, P Gilleaudeau, ... Journal of the American Academy of Dermatology 83 (5), 1341-1348, 2020 | 84 | 2020 |
| Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaire DF Sebaratnam, AM Hanna, S Chee, JW Frew, SS Venugopal, BS Daniel, ... JAMA dermatology 149 (10), 1186-1191, 2013 | 84 | 2013 |
| A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa JW Frew, DA Vekic, J Woods, GD Cains British Journal of Dermatology 177 (4), 987-998, 2017 | 79 | 2017 |
| A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa JW Frew, JE Hawkes, JG Krueger F1000Research 7, 2018 | 78 | 2018 |
| Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome). JW Frew, DF Murrell Dermatologic clinics 29 (4), 607-612, 2011 | 75 | 2011 |
| The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in … A Tjokrowidjaja, BS Daniel, JW Frew, DF Sebaratnam, AM Hanna, ... British Journal of Dermatology 169 (5), 1000-1006, 2013 | 74 | 2013 |
| Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms JW Frew, JE Hawkes, JG Krueger Therapeutic Advances in Chronic Disease 10, 2040622319830646, 2019 | 71 | 2019 |
| Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa K Navrazhina, JW Frew, P Gilleaudeau, M Sullivan-Whalen, S Garcet, ... Journal of Allergy and Clinical Immunology 147 (6), 2213-2224, 2021 | 61 | 2021 |
| Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. JW Frew, DF Murrell Dermatologic clinics 29 (3), 419-25, viii, 2011 | 61 | 2011 |
| Hidradenitis suppurativa is an autoinflammatory keratinization disease: a review of the clinical, histologic, and molecular evidence JW Frew JAAD international 1 (1), 62-72, 2020 | 59 | 2020 |
| Inter‐rater reliability of phenotypes and exploratory genotype–phenotype analysis in inherited hidradenitis suppurativa JW Frew, JE Hawkes, M Sullivan‐Whalen, P Gilleaudeau, JG Krueger British Journal of Dermatology 181 (3), 566-571, 2019 | 58 | 2019 |
| Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1 DA Vekic, J Frew, GD Cains Australasian Journal of Dermatology 59 (4), 267-277, 2018 | 55 | 2018 |
| Multinucleate cell angiohistiocytoma: clinicopathological correlation of 142 cases with insights into etiology and pathogenesis JW Frew The American Journal of Dermatopathology 37 (3), 222-228, 2015 | 50 | 2015 |
| A systematic review of promising therapeutic targets in hidradenitis suppurativa: a critical evaluation of mechanistic and clinical relevance JW Frew, AV Marzano, K Wolk, O Join-Lambert, A Alavi, MA Lowes, ... Journal of Investigative Dermatology 141 (2), 316-324. e2, 2021 | 45 | 2021 |
| Clinical response rates, placebo response rates, and significantly associated covariates are dependent on choice of outcome measure in hidradenitis suppurativa: a post hoc … JW Frew, CS Jiang, N Singh, D Grand, K Navrazhina, R Vaughan, ... Journal of the American Academy of Dermatology 82 (5), 1150-1157, 2020 | 45 | 2020 |
Dedee Murrell MA (Cambridge) BMBC...Professor & Dept Head, Dermatology, St George Hospital, University of NSW, Sydney, AustraliaVerified email at unsw.edu.au
